Biumi Bonnie

Director · CZR, HZO, KRG

As of 2026-09-16, Biumi Bonnie has 9 Form 4 transactions on record across 3 companies — 5 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Reconstructed holdings

Direct: $3.5MIndirect: $0$3.5Mas of 2026-09-16
  • Direct $3.5M
  • Indirect $0
KRGdirect73,680 sh$1.9M
CZRdirect43,149 sh$1.3M
HZOdirect6,309 sh$330K

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

HZO · 5 trades
2025-11-17: Award / grant, 6,309 sh ($0)2025-11-14: Option exercise, 4,633 sh ($0)2025-11-14: Option exercise, 4,633 sh ($0)2025-03-11: Purchase, 1,000 sh ($23K)2025-02-24: Purchase, 1,000 sh ($27K)
CZR · 3 trades
2026-01-23: Award / grant, 10,369 sh ($0)2025-10-31: Purchase, 1,000 sh ($19K)2025-01-24: Award / grant, 7,552 sh ($0)
KRG · 1 trade
2025-05-16: Award / grant, 5,611 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2025-10-31CZRPurchase1,000 @ $18.69$19K+3.1% of holding32,780Form 4
2025-03-11HZOPurchase1,000 @ $23.37$23K+100.0% of holding2,000Form 4
2025-02-24HZOPurchase1,000 @ $26.50$27Kownership Δ n/a1,000Form 4
6 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-01-23CZRAward / grant10,36943,149Form 4
2025-11-17HZOAward / grant6,3096,309Form 4
2025-11-14HZOOption exercise4,6336,633Form 4
2025-11-14HZOOption exercise4,6330Form 4
2025-05-16KRGAward / grant5,61173,680Form 4
2025-01-24CZRAward / grant7,55231,780Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.